10 years experiences and trusting networks between Japan and the global market

Global Ecosystems 

Open Innovation 

Proactive Business Development 

Technology Management 

Technology Scouting  

IP Management 

INNOVATIONS

 

Biospire identifies innovative technologies and high potential businesses from the global market to connect to global stakeholders including corporate (open innovation, CVC, R&D), investors and ecosystems.

AdobeStock_198333071.jpeg

Digital therapeutics for autism therapy

Digital therapy and diagnostic device developed for ADHD, ASD and Schizophrenia using tablet like iPad

Impute

AdobeStock_198333071.jpeg

Chemically synthesizable mycoplasma antigens for vaccine development

M Biotech has key patents related to the structure of glycolipid on mycoplasma membrane surfaces as well as its synthesis methodology. These technologies can be applied to highly sensitive diagnoses and vaccine development using the glycolipid-antigen to produce its antibody. M Biotech is en-route to global business expansion by collaborating with business and technical partners.

Mycoplasma

M Bio Technology

AdobeStock_198333071.jpeg

VR for healthcare approaches

FOVE uses a unique eye tracking VR system, and is now looking for healthcare application partners such as dementia (cognitive) research fields, e.g. self-check device development.

VR

FOVE

AdobeStock_198333071.jpeg

Indoor hypoallergenic spray for reduction of fine dust particles and PM2.5

Herb Guardian invented the novel technology to combat the hazardous fine particulate matters in the atmosphere. They are a spinout company from Chulalongkorn University in Thailand.

Environmental particles

Herb Guardian

AdobeStock_198333071.jpeg

License-free big surgical data from Japanese hospitals

Surg storage is a spin out of the National Cancer Hospital in Japan and can now provide surgical videos and surgical-related data for commercial use such as the quality improvement of medical devices.

Surgical data

Surg storage

AdobeStock_198333071.jpeg

iPSC derived artificial immature blood cells

MiCAN develops iPS-derived myeloid (immature dendritic cells) to be applied for virus research (including dengue and COVID-19) as well as for drug safety applications.

Regenerative medicine

MiCAN

AdobeStock_198333071.jpeg

Probiotics technology suppressing methane gas production in cows' stomach

JFR collaborates with academia to develop technologies to supress methane gas (CH4) generations from livestock animals using own probiotics know-hows.

Biotechnology, probiotics

JFR

AdobeStock_198333071.jpeg

iPSC derived corneal endothelial cellular therapy

Cellusion owns IP and technologies to develop and obtain iPS-derived corneal endothelial cells suitable for corneal transplantation. They aim to derive enough therapeutic cells to treat thousands of patients from a single batch.

Regenerative medicine

Cellusion

AdobeStock_198333071.jpeg

Super high pure, pluripotentable and scalable MSC

PuREC is a spinout from Shimane University with patented technologies to produce purified MSC, or mesenchymal stem cells. PuREC's REC is coming from Rapidly Expanding Cells enabling the synthesis of 10^12 ordered pure cells within 12 weeks without requiring complicated methodologies such as gene-modification.

Regenerative medicine

PuREC

Japan to Global

Why don't you explore your investment and business acquisition targets to high-end Japanese startup companies?

Biospire selects and supports best-in-class Japanese startup companies looking for global communications, collaborations, business development and investments. 

Biospire introduces suitable startups to international stakeholders through an integrated endorsement system.

Endorsement of selected Japanese startup companies

Japan is increasingly recognized a great place to invest, however we know that it is difficult to identify the most promising and valuable startups. Biospire’s experienced consultant team endorses hand-selected startup companies using our vast experience and databases.

Proactive global business development support

Japanese startups may be missing a large international market. Many early-stage startups have not established clear global strategies. Biospire's global business experts will guide you to deliver global marketing, partnering you with the best investors and the supply chain management.

Global to Japan

Japan is a great place to explore your businesses. Our business development experts are fully versed in Japanese business culture to bridge you and the best business partners. 

Biospire links to local ecosystems, government, distributors, business development specialists including sole-reps, and of course high value end-users. 

Proactive & strategic business entry support

We understand Japan’s unique business culture. This extends beyond language and supply chain complications. Business is built on key decision making through relationship development and trust based on culture.  Biospire will be your business advisor to guide you to build the best strategies to enter the Japanese market.

Primary contact for your business transaction in Japan

Contracts with distributors, end users and legal entities are complicated in Japan. 
Biospire is a Japanese legal entity that works as your account to facilitate your business.

We partner with leading innovative companies looking for international collaborations

To play, press and hold the enter key. To stop, release the enter key.

press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
press to zoom
 

WHAT'S NEW

CONTACT US TODAY

 

Thanks for submitting!